Literature DB >> 15900085

Effect of ajmaline on transient outward current in rat ventricular myocytes.

M Bébarová1, P Matejovic, M Pásek, M Simurdová, J Simurda.   

Abstract

The mechanism of ajmaline-induced inhibition of the transient outward current (I(to)) has been investigated in right ventricular myocytes of rat using the whole cell patch clamp technique. Ajmaline decreased the amplitude and the time integral of I(to) in a concentration-dependent, but frequency- and use-independent manner. In contrast to the single exponential time course of I(to)-inactivation in control conditions (tau(i) = 37.1 +/- 2.7 ms), the apparent inactivation was fitted by a sum of two exponentials under the effect of ajmaline with concentration-dependent fast and slow components (tau(f) = 11.7 +/- 0.8 ms, tau(s) = 57.6 +/- 2.7 ms at 10 micromol/l) suggesting block development primarily in the open channel state. An improved expression enabling to calculate the association and dissociation rate constants from the concentration dependence of tau(f) and tau(s) was derived and resulted in k(on) = 4.57 x 10(6) +/- 0.32 x 10(6) mol(-1).l.s(-1) and k(off) = 20.12 +/- 5.99 s(-1). The value of K(d) = 4.4 micromol/l calculated as k(off) / k(on) was considerably lower than IC(50) = 25.9 +/- 2.9 micromol/l evaluated from the concentration dependence of the integrals of I(to). Simulations on a simple model combining Hodgkin-Huxley type gating kinetics and drug-channel interaction entirely in open channel state agreed well with the experimental data including the difference between the K(d) and IC(50). According to the model, the fraction of blocked channels increases upon depolarization and declines if depolarization is prolonged. The repolarizing step induces recovery from block with time constant of 52 ms. We conclude that in the rat right ventricular myocytes, ajmaline is an open channel blocker with fast recovery from the block at resting voltage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15900085

Source DB:  PubMed          Journal:  Gen Physiol Biophys        ISSN: 0231-5882            Impact factor:   1.512


  8 in total

1.  Inhibition of cardiac Kv1.5 and Kv4.3 potassium channels by the class Ia anti-arrhythmic ajmaline: mode of action.

Authors:  F Fischer; N Vonderlin; E Zitron; C Seyler; D Scherer; R Becker; H A Katus; E P Scholz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-07-06       Impact factor: 3.000

2.  Nicotine at clinically relevant concentrations affects atrial inward rectifier potassium current sensitive to acetylcholine.

Authors:  Markéta Bébarová; Peter Matejovič; Olga Švecová; Roman Kula; Milena Šimurdová; Jiří Šimurda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-02-03       Impact factor: 3.000

3.  Modulation of angiogenesis by dithiolethione-modified NSAIDs and valproic acid.

Authors:  J S Isenberg; Y Jia; L Field; L A Ridnour; A Sparatore; P Del Soldato; A L Sowers; G C Yeh; T W Moody; D A Wink; R Ramchandran; D D Roberts
Journal:  Br J Pharmacol       Date:  2007-03-12       Impact factor: 8.739

4.  Why Is Only Type 1 Electrocardiogram Diagnostic of Brugada Syndrome? Mechanistic Insights From Computer Modeling.

Authors:  Zhaoyang Zhang; Peng-Sheng Chen; James N Weiss; Zhilin Qu
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-12-29

5.  Fraction of the T-Tubular Membrane as an Important Parameter in Cardiac Cellular Electrophysiology: A New Way of Estimation.

Authors:  Olga Švecová; Markéta Bébarová; Milena Šimurdová; Jiří Šimurda
Journal:  Front Physiol       Date:  2022-05-10       Impact factor: 4.755

6.  Effect of antipsychotic drug perphenazine on fast sodium current and transient outward potassium current in rat ventricular myocytes.

Authors:  Markéta Bébarová; Peter Matejovic; Michal Pásek; Dagmar Jansová; Milena Simurdová; Marie Nováková; Jirí Simurda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-05-09       Impact factor: 3.000

7.  Ajmaline blocks INa and IKr without eliciting differences between Brugada syndrome patient and control human pluripotent stem cell-derived cardiac clusters.

Authors:  Duncan C Miller; Stephen C Harmer; Ariel Poliandri; Muriel Nobles; Elizabeth C Edwards; James S Ware; Tyson V Sharp; Tristan R McKay; Leo Dunkel; Pier D Lambiase; Andrew Tinker
Journal:  Stem Cell Res       Date:  2017-11-07       Impact factor: 2.020

Review 8.  The Mechanism of Ajmaline and Thus Brugada Syndrome: Not Only the Sodium Channel!

Authors:  Michelle M Monasky; Emanuele Micaglio; Sara D'Imperio; Carlo Pappone
Journal:  Front Cardiovasc Med       Date:  2021-12-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.